Log in to save to my catalogue

Cross-Platform Validation of Neurotransmitter Release Impairments in Schizophrenia Patient-Derived N...

Cross-Platform Validation of Neurotransmitter Release Impairments in Schizophrenia Patient-Derived N...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2507275363

Cross-Platform Validation of Neurotransmitter Release Impairments in Schizophrenia Patient-Derived NRXN1-Mutant Neurons

About this item

Full title

Cross-Platform Validation of Neurotransmitter Release Impairments in Schizophrenia Patient-Derived NRXN1-Mutant Neurons

Publisher

Cold Spring Harbor: Cold Spring Harbor Laboratory Press

Journal title

bioRxiv, 2020-11

Language

English

Formats

Publication information

Publisher

Cold Spring Harbor: Cold Spring Harbor Laboratory Press

More information

Scope and Contents

Contents

ABSTRACT Heterozygous NRXN1 deletions constitute the most prevalent currently known single-gene mutation predisposing to schizophrenia. Previous studies showed that engineered heterozygous NRXN1 deletions impaired neurotransmitter release in human neurons, suggesting a synaptic pathophysiological mechanism. Utilizing this observation for drug disco...

Alternative Titles

Full title

Cross-Platform Validation of Neurotransmitter Release Impairments in Schizophrenia Patient-Derived NRXN1-Mutant Neurons

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_journals_2507275363

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2507275363

Other Identifiers

E-ISSN

2692-8205

DOI

10.1101/2020.11.03.366617